Work

Canagliflozin (invokana), a novel oral agent for type-2 diabetes.

Year: 2013

Type: article

Abstract: Canagliflozin (Invokana) for type-2 diabetes

Source: PubMed

Authors: Sheila Sarnoski-Brocavich, Olga Hilas

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W2110729979

FWCI: 0.814

Cites: 15

Cited by: 19

Related to: 10